Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 9392132, 18 pages
http://dx.doi.org/10.1155/2016/9392132
Review Article

Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases

1Center of Laboratory Medicine, The General Hospital of Ningxia Medical University, Yinchuan 750004, China
2Department of Rheumatology, The General Hospital of Ningxia Medical University, Yinchuan 750004, China
3Key Laboratory of the Ministry of Education for the Conservation and Utilization of Special Biological Resources of Western China, Ningxia University, Yinchuan, Ningxia 750021, China
4Institute of Human Stem Cell Research at the General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China

Received 21 December 2015; Revised 5 March 2016; Accepted 9 March 2016

Academic Editor: Paola Nistico

Copyright © 2016 Juan Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Wahren-Herlenius and T. Dörner, “Immunopathogenic mechanisms of systemic autoimmune disease,” The Lancet, vol. 382, no. 9894, pp. 819–831, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Koutsokeras and T. Healy, “Systemic lupus erythematosus and lupus nephritis,” Nature Reviews Drug Discovery, vol. 13, no. 3, pp. 173–174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Benson, J. M. Brewer, and A. M. Platt, “Mechanisms of autoimmunity in human diseases: a critical review of current dogma,” Current Opinion in Rheumatology, vol. 26, no. 2, pp. 197–203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Rosenblum, K. A. Remedios, and A. K. Abbas, “Mechanisms of human autoimmunity,” Journal of Clinical Investigation, vol. 125, no. 6, pp. 2228–2233, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Nusse, “Cell signalling: disarming Wnt,” Nature, vol. 519, no. 7542, pp. 163–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Hauck, F. Hofmaier, J. Dietter et al., “Label-free LC-MSMS analysis of vitreous from autoimmune uveitis reveals a significant decrease in secreted Wnt signalling inhibitors DKK3 and SFRP2,” Journal of Proteomics, vol. 75, no. 14, pp. 4545–4554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Schett, J. Zwerina, and J.-P. David, “The role of Wnt proteins in arthritis,” Nature Clinical Practice Rheumatology, vol. 4, no. 9, pp. 473–480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. A. Tveita and O. P. Rekvig, “Alterations in Wnt pathway activity in mouse serum and kidneys during lupus development,” Arthritis and Rheumatism, vol. 63, no. 2, pp. 513–522, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Beyer, A. Schramm, A. Akhmetshina et al., “β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 71, no. 5, pp. 761–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. T. Moon, A. D. Kohn, G. V. De Ferrari, and A. Kaykas, “WNT and β-catenin signalling: diseases and therapies,” Nature Reviews Genetics, vol. 5, no. 9, pp. 691–701, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. X.-D. Wang, X.-F. Huang, Q.-R. Yan, and C.-D. Bao, “Aberrant activation of the WNT/β-catenin signaling pathway in lupus nephritis,” PLoS ONE, vol. 9, no. 1, Article ID e84852, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Yuan, Y. Shi, and S.-J. Tang, “Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain,” Journal of Neuroimmune Pharmacology, vol. 7, no. 4, pp. 904–913, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Komiya and R. Habas, “Wnt signal transduction pathways,” Organogenesis, vol. 4, no. 2, pp. 68–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Yang, X. Wang, H. Zhang et al., “The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies,” Laboratory Investigation, vol. 96, no. 2, pp. 116–136, 2016. View at Publisher · View at Google Scholar
  15. D. Tai, K. Wells, J. Arcaroli et al., “Targeting the WNT signaling pathway in cancer therapeutics,” Oncologist, vol. 20, no. 10, pp. 1189–1198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. F. Xiao, X. Yong, B. Tang et al., “Notch and Wnt signaling pathway in cancer: crucial role and potential therapeutic targets (review),” International Journal of Oncology, vol. 48, no. 2, pp. 437–449, 2015. View at Publisher · View at Google Scholar
  17. M. Corr, “Wnt signaling in ankylosing spondylitis,” Clinical Rheumatology, vol. 33, no. 6, pp. 759–762, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Sen, J. Reifert, K. Lauterbach et al., “Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes,” Arthritis and Rheumatism, vol. 46, no. 11, pp. 2867–2877, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Wei, D. Melichian, K. Komura et al., “Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?” Arthritis and Rheumatism, vol. 63, no. 6, pp. 1707–1717, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Tury, K. Tolentino, and Y. Zou, “Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis,” Developmental Neurobiology, vol. 74, no. 8, pp. 839–850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Tamai, M. Semenov, Y. Kato et al., “LDL-receptor-related proteins in Wnt signal transduction,” Nature, vol. 407, no. 6803, pp. 530–535, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. R. T. Moon, B. Bowerman, M. Boutros, and N. Perrimon, “The promise and perils of Wnt signaling through β-catenin,” Science, vol. 296, no. 5573, pp. 1644–1646, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Niehrs, “The complex world of WNT receptor signalling,” Nature Reviews Molecular Cell Biology, vol. 13, no. 12, pp. 767–779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Gómez-Orte, B. Sáenz-Narciso, S. Moreno, and J. Cabello, “Multiple functions of the noncanonical Wnt pathway,” Trends in Genetics, vol. 29, no. 9, pp. 545–553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. T. Veeman, J. D. Axelrod, and R. T. Moon, “A second canon: functions and mechanisms of β-catenin-independent Wnt signaling,” Developmental Cell, vol. 5, no. 3, pp. 367–377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Kikuchi, H. Yamamoto, A. Sato, and S. Matsumoto, “New insights into the mechanism of Wnt signaling pathway activation,” International Review of Cell and Molecular Biology, vol. 291, pp. 21–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Malinauskas and E. Y. Jones, “Extracellular modulators of Wnt signalling,” Current Opinion in Structural Biology, vol. 29, pp. 77–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Niehrs, “Function and biological roles of the Dickkopf family of Wnt modulators,” Oncogene, vol. 25, no. 57, pp. 7469–7481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Mao and C. Niehrs, “Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling,” Gene, vol. 302, no. 1-2, pp. 179–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Liang, H. He, R. Lv et al., “Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma,” Tumor Biology, vol. 36, no. 2, pp. 1245–1250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Gattinoni, X.-S. Zhong, D. C. Palmer et al., “Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells,” Nature Medicine, vol. 15, no. 7, pp. 808–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Swafford and S. Manicassamy, “Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance,” Discovery Medicine, vol. 19, no. 105, pp. 303–310, 2015. View at Google Scholar · View at Scopus
  33. M. J. Koslowski, Z. Teltschik, J. Beisner et al., “Association of a functional variant in the wnt co-receptor LRP6 with early onset ileal Crohn's disease,” PLoS Genetics, vol. 8, no. 2, Article ID e1002523, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-G. Miao, C. Huang, Y. Huang et al., “MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats,” Cellular Signalling, vol. 25, no. 3, pp. 598–608, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. G. Miao, D. Qin, C. L. Du et al., “DNMT1 activates the canonical Wnt signaling in rheumatoid arthritis model rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2,” International Immunopharmacology, vol. 28, no. 1, pp. 344–353, 2015. View at Publisher · View at Google Scholar
  36. A. Ahmadzadeh, F. Norozi, S. Shahrabi, M. Shahjahani, and N. Saki, “Wnt/β-catenin signaling in bone marrow niche,” Cell and Tissue Research, vol. 363, no. 2, pp. 321–335, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. F. J. T. Staal, T. C. Luis, and M. M. Tiemessen, “WNT signalling in the immune system: WNT is spreading its wings,” Nature Reviews Immunology, vol. 8, no. 8, pp. 581–593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. B. M. Abidin, E. O. Kwarteng, and K. M. Heinonen, “Frizzled-6 regulates hematopoietic stem/progenitor cell survival and self-renewal,” Journal of Immunology, vol. 195, no. 5, pp. 2168–2176, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Ma, R. Wang, X. Fang, and Z. Sun, “β-catenin/TCF-1 pathway in T cell development and differentiation,” Journal of Neuroimmune Pharmacology, vol. 7, no. 4, pp. 750–762, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Ye, J. Zhang, J. Wang et al., “CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study,” Arthritis Research and Therapy, vol. 17, article 76, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Ding, S. Shen, A. C. Lino, M. A. Curotto De Lafaille, and J. J. Lafaille, “Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells,” Nature Medicine, vol. 14, no. 2, pp. 162–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. J. vanLoosdregt, V. Fleskens, M. Tiemessen et al., “Canonical WNT signaling negatively modulates regulatory T cell function,” Immunity, vol. 39, no. 2, pp. 298–310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Kotake and Y. Nanke, “Effect of TNFα on osteoblastogenesis from mesenchymal stem cells,” Biochimica et Biophysica Acta—General Subjects, vol. 1840, no. 3, pp. 1209–1213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Choi, J. R. Arron, and M. J. Townsend, “Promising bone-related therapeutic targets for rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 5, no. 10, pp. 543–548, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. J. Pinzone, B. M. Hall, N. K. Thudi et al., “The role of Dickkopf-1 in bone development, homeostasis, and disease,” Blood, vol. 113, no. 3, pp. 517–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Cheon, D. L. Boyle, and G. S. Firestein, “Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis,” Journal of Rheumatology, vol. 31, no. 11, pp. 2106–2114, 2004. View at Google Scholar · View at Scopus
  47. M. Sen, M. Chamorro, J. Reifert, M. Corr, and D. A. Carson, “Blockade of Wnt-5A/Frizzled 5 signaling inhibits rheumatoid synoviocyte activation,” Arthritis and Rheumatism, vol. 44, no. 4, pp. 772–781, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Nakamura, M. Nawata, and S. Wakitani, “Expression profiles and functional analyses of Wnt-related genes in human joint disorders,” American Journal of Pathology, vol. 167, no. 1, pp. 97–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Roser-Page, T. Vikulina, M. Zayzafoon, and M. N. Weitzmann, “CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model,” Arthritis and Rheumatology, vol. 66, no. 4, pp. 990–999, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Daoussis, S.-N. C. Liossis, E. E. Solomou et al., “Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 150–158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Briolay, P. Lencel, L. Bessueille, J. Caverzasio, R. Buchet, and D. Magne, “Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells,” Biochemical and Biophysical Research Communications, vol. 430, no. 3, pp. 1072–1077, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Assassi and M. D. Mayes, “What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?” Current Opinion in Rheumatology, vol. 25, no. 6, pp. 686–691, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Wei, F. Fang, A. P. Lam et al., “Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells,” Arthritis and Rheumatism, vol. 64, no. 8, pp. 2734–2745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Antic, J. H. W. Distler, and O. Distler, “Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?” Current Opinion in Pharmacology, vol. 13, no. 3, pp. 455–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Svegliati, G. Marrone, A. Pezone et al., “Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis,” Science Signaling, vol. 7, no. 341, p. ra84, 2014. View at Google Scholar
  56. J. Huelsken, R. Vogel, B. Erdmann, G. Cotsarelis, and W. Birchmeier, “β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin,” Cell, vol. 105, no. 4, pp. 533–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Suo, J. P. Sundberg, and H. B. Everts, “Dietary vitamin A regulates wingless-related MMTV integration site signaling to alter the hair cycle,” Experimental Biology and Medicine, vol. 240, no. 5, pp. 618–623, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Fukuda, L. Chen, T. Endo et al., “Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 3047–3052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. M. C. T. Novo, L. Osugui, V. O. dos Reis, I. M. Longo-Maugéri, M. Mariano, and A. F. Popi, “Blockage of Wnt/β-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro,” Immunobiology, vol. 220, no. 1, pp. 60–67, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. P.-P. Li, L.-L. Feng, N. Chen et al., “Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway,” Medical Oncology, vol. 32, no. 2, p. 479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. Q. M. Yao, P. P. Li, S. M. Liang et al., “Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 7, pp. 7921–7928, 2015. View at Google Scholar
  62. F. Wei, Y. Zhang, W. Zhao, X. Yu, and C.-J. Liu, “Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions,” PLoS ONE, vol. 9, no. 11, Article ID e112110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. C. von Toerne, C. Sieg, U. Kaufmann, M. Diedrichs-Möhring, P. J. Nelson, and G. Wildner, “Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signatures,” Molecular Immunology, vol. 48, no. 1–3, pp. 272–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. M. J. Koslowski, I. Kübler, M. Chamaillard et al., “Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease,” PLoS ONE, vol. 4, no. 2, Article ID e4496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Beisner, Z. Teltschik, M. J. Ostaff et al., “TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 307, no. 5, pp. G487–G498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. J. R. Calabrese, A. D. Gulledge, K. Hahn et al., “Autoimmune thyroiditis in manic-depressive patients treated with lithium,” The American Journal of Psychiatry, vol. 142, no. 11, pp. 1318–1321, 1985. View at Publisher · View at Google Scholar · View at Scopus
  67. J. E. Gudjonsson, A. Johnston, S. W. Stoll et al., “Evidence for altered Wnt signaling in psoriatic skin,” Journal of Investigative Dermatology, vol. 130, no. 7, pp. 1849–1859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Gu, W. Tan, G. Feng et al., “Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway,” Molecular and Cellular Biochemistry, vol. 387, no. 1-2, pp. 27–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Mussmann, M. Geese, F. Harder et al., “Inhibition of GSK3 promotes replication and survival of pancreatic beta cells,” Journal of Biological Chemistry, vol. 282, no. 16, pp. 12030–12037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Wang, J. R. Walker, X. Wang et al., “Identification of small-molecule inducers of pancreatic β-cell expansion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1427–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. L. J. Vuga, A. Ben-Yehudah, E. Kovkarova-Naumovski et al., “WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 5, pp. 583–589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Krasoudaki, A. Banos, E. Stagakis et al., “Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4,” Nephrology Dialysis Transplantation, 2015. View at Publisher · View at Google Scholar
  73. M. Capuano, L. Iaffaldano, N. Tinto et al., “MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients,” PLoS ONE, vol. 6, no. 12, Article ID e29094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. C.-G. Miao, W.-J. Shi, Y.-Y. Xiong et al., “MicroRNA-663 activates the canonical Wnt signaling through the adenomatous polyposis coli suppression,” Immunology Letters, vol. 166, no. 1, pp. 45–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Sun, P. Yan, Y. Chen et al., “MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway,” Diagnostic Pathology, vol. 10, article 72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Li, P. Zhang, and J. Gu, “miR-29a modulates tumor necrosis factor-α-induced osteogenic inhibition by targeting Wnt antagonists,” Development Growth and Differentiation, vol. 57, no. 3, pp. 264–273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. C.-G. Miao, Y.-Y. Yang, X. He et al., “MicroRNA-152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model,” Biochimie, vol. 106, pp. 149–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. C.-G. Miao, W.-J. Shi, Y.-Y. Xiong et al., “MiR-375 regulates the canonical Wnt pathway through FZD8 silencing in arthritis synovial fibroblasts,” Immunology Letters, vol. 164, no. 1, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Bao and X. Cao, “The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review,” Journal of Autoimmunity, vol. 55, no. 1, pp. 10–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Tokuda, M. Tanaka, T. Yagi, and K. Tashiro, “The defect of SFRP2 modulates an influx of extracellular calcium in B lymphocytes,” BMC Research Notes, vol. 7, article 780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Muralidharan, P. J. Hanley, E. Liu et al., “Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes,” Journal of Immunology, vol. 187, no. 10, pp. 5221–5232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Suryawanshi, I. Manoharan, Y. Hong et al., “Canonical Wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation,” Journal of Immunology, vol. 194, no. 7, pp. 3295–3304, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. P. M. Bhatt and R. Malgor, “Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders,” Atherosclerosis, vol. 237, no. 1, pp. 155–162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Valencia, C. Hernández-López, V. G. Martínez et al., “Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features,” Journal of Immunology, vol. 187, no. 8, pp. 4129–4139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Holtzhausen, F. Zhao, K. S. Evans et al., “Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy,” Cancer Immunology Research, vol. 3, no. 9, pp. 1082–1095, 2015. View at Publisher · View at Google Scholar
  86. C. Oderup, M. LaJevic, and E. C. Butcher, “Canonical and noncanonical Wnt proteins program dendritic cell responses for tolerance,” Journal of Immunology, vol. 190, no. 12, pp. 6126–6134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Manicassamy, B. Reizis, R. Ravindran et al., “Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine,” Science, vol. 329, no. 5993, pp. 849–853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Wienke, W. Janssen, R. Scholman et al., “A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation,” Oncotarget, vol. 6, no. 24, pp. 20037–20042, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Lamagna, P. Scapini, J. A. Van Ziffle, A. L. DeFranco, and C. A. Lowell, “Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 35, pp. E3311–E3320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. W. Liu and X. Zhang, “Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review),” Molecular Medicine Reports, vol. 11, no. 5, pp. 3212–3218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Salt and L. Crofford, “Rheumatoid arthritis: new treatments, better outcomes,” Nurse Practitioner, vol. 37, no. 11, pp. 16–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Sen, K. Lauterbach, H. El-Gabalawy, G. S. Firestein, M. Corr, and D. A. Carson, “Expression and function of wingless and frizzled homologs in rheumatoid arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2791–2796, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. Z. Zhong, N. J. Ethen, and B. O. Williams, “WNT signaling in bone development and homeostasis,” Wiley Interdisciplinary Reviews: Developmental Biology, vol. 3, no. 6, pp. 489–500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. C.-G. Miao, Y.-Y. Yang, X. He et al., “Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling,” Cellular Signalling, vol. 25, no. 10, pp. 2069–2078, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. D. Daoussis and A. P. Andonopoulos, “The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?” Seminars in Arthritis and Rheumatism, vol. 41, no. 2, pp. 170–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. D. E. Furst and P. Emery, “Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets,” Rheumatology, vol. 53, no. 9, Article ID ket414, pp. 1560–1569, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Braun and J. Sieper, “Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-α therapy and other novel approaches,” Arthritis Research, vol. 4, no. 5, pp. 307–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Diarra, M. Stolina, K. Polzer et al., “Dickkopf-1 is a master regulator of joint remodeling,” Nature Medicine, vol. 13, no. 2, pp. 156–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Uderhardt, D. Diarra, J. Katzenbeisser et al., “Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints,” Annals of the Rheumatic Diseases, vol. 69, no. 3, pp. 592–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. Z. Hu, M. Xu, Q. Li et al., “Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis,” International Journal of Rheumatic Diseases, vol. 15, no. 4, pp. 358–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. S. E. Ross, N. Hemati, K. A. Longo et al., “Inhibition of adipogenesis by Wnt signaling,” Science, vol. 289, no. 5481, pp. 950–953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  102. S.-R. Kwon, M.-J. Lim, C.-H. Suh et al., “Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy,” Rheumatology International, vol. 32, no. 8, pp. 2523–2527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. G. R. Heiland, H. Appel, D. Poddubnyy et al., “High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 71, no. 4, pp. 572–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. J. Deng, Z. X. Huang, C. J. Zhou et al., “Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus,” Molecular Immunology, vol. 43, no. 9, pp. 1497–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. Y.-J. Sheng, J.-P. Gao, J. Li et al., “Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus,” Rheumatology, vol. 50, no. 4, pp. 682–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Long, Y. Liu, S. Wang et al., “Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus,” Journal of Clinical Immunology, vol. 30, no. 5, pp. 669–675, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. A. T. Naito, T. Sumida, S. Nomura et al., “Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes,” Cell, vol. 149, no. 6, pp. 1298–1313, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Tan, D. Song, L.-H. Wu, F. Yu, and M.-H. Zhao, “Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis,” BMC Nephrology, vol. 14, no. 1, article 63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. D. Wang, S. Huang, X. Yuan et al., “The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus,” Cellular and Molecular Immunology, 2015. View at Publisher · View at Google Scholar
  110. T. Yamaza, A. Kentaro, C. Chen et al., “Immunomodulatory properties of stem cells from human exfoliated deciduous teeth,” Stem Cell Research and Therapy, vol. 1, no. 1, article 5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. Y.-S. Lee, K.-A. Lee, H.-B. Yoon et al., “The Wnt inhibitor secreted frizzled-related protein 1 (sFRP1) promotes human Th17 differentiation,” European Journal of Immunology, vol. 42, no. 10, pp. 2564–2573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. H. S. Bandukwala and A. Rao, “'Nurr'ishing Treg cells: Nr4a transcription factors control Foxp3 expression,” Nature immunology, vol. 14, no. 3, pp. 201–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. H. Kitagawa, W. J. Ray, H. Glantschnig et al., “A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling,” Molecular and Cellular Biology, vol. 27, no. 21, pp. 7486–7496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. E. W. Choi, H. W. Lee, S. Shin et al., “Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig overproducing xenogeneic adipose tissue-derived mesenchymal stem cells on murine systemic lupus erythematosus,” Cell Transplantation, 2015. View at Publisher · View at Google Scholar
  115. N. Che, X. Li, L. Zhang et al., “Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCl2 expression,” Journal of Immunology, vol. 193, no. 10, pp. 5306–5314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Fujimaki, T. Wakabayashi, T. Takemasa et al., “The regulation of stem cell aging by Wnt signaling,” Histology and Histopathology, vol. 30, no. 12, pp. 1411–1430, 2015. View at Google Scholar
  117. E. Leah, “Connective tissue diseases: epigenetic silencing of Wnt inhibition in systemic sclerosis,” Nature Reviews Rheumatology, vol. 9, no. 7, p. 384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. C. Bergmann, A. Akhmetshina, C. Dees et al., “Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway,” Annals of the Rheumatic Diseases, vol. 70, no. 12, pp. 2191–2198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. A. Distler, L. Deloch, J. Huang et al., “Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling,” Annals of the Rheumatic Diseases, vol. 72, no. 9, pp. 1575–1580, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. M. Königshoff, M. Kramer, N. Balsara et al., “WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis,” The Journal of Clinical Investigation, vol. 119, no. 4, pp. 772–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. E. G. Quetglas, “Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease,” World Journal of Gastroenterology, vol. 21, no. 44, p. 12519, 2015. View at Publisher · View at Google Scholar
  122. M. M. H. Claessen, M. E. I. Schipper, B. Oldenburg, P. D. Siersema, G. J. A. Offerhaus, and F. P. Vleggaar, “WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance,” Cellular Oncology, vol. 32, no. 4, pp. 303–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. T. Tuller, S. Atar, E. Ruppin, M. Gurevich, and A. Achiron, “Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases,” Genes and Immunity, vol. 14, no. 2, pp. 67–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. G. Rogler, “Chronic ulcerative colitis and colorectal cancer,” Cancer Letters, vol. 345, no. 2, pp. 235–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. K. R. Hughes, F. Sablitzky, and Y. R. Mahida, “Expression profiling of Wnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells,” Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 213–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. J. You, A. V. Nguyen, C. G. Albers, F. Lin, and R. F. Holcombe, “Wnt pathway-related gene expression in inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 53, no. 4, pp. 1013–1019, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. H. van Dekken, J. C. Wink, K. J. Vissers et al., “Wnt pathway-related gene expression during malignant progression in ulcerative colitis,” Acta Histochemica, vol. 109, no. 4, pp. 266–272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Gersemann, E. F. Stange, and J. Wehkamp, “From intestinal stem cells to inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 17, no. 27, pp. 3198–3203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Cosín-Roger, D. Ortiz-Masiá, S. Calatayud et al., “M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis,” PLoS ONE, vol. 8, no. 10, Article ID e78128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Sato, H. Kayama, K. Shojima et al., “The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis,” Scientific Reports, vol. 5, Article ID 10536, 2015. View at Publisher · View at Google Scholar · View at Scopus
  131. J. Cosín-Roger, D. Ortiz-Masiá, S. Calatayud, C. Hernández, J. V. Esplugues, and M. D. Barrachina, “The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD,” Mucosal Immunology, 2015. View at Publisher · View at Google Scholar
  132. M. Dhir, E. A. Montgomery, S. C. Glöckner et al., “Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia,” Journal of Gastrointestinal Surgery, vol. 12, no. 10, pp. 1745–1753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. A. Serafino, N. Moroni, M. Zonfrillo et al., “WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer,” Oncotarget, vol. 5, no. 4, pp. 978–992, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. Y. Xing, X. Chen, Y. Cao, J. Huang, X. Xie, and Y. Wei, “Expression of Wnt and Notch signaling pathways in inflammatory bowel disease treated with mesenchymal stem cell transplantation: evaluation in a rat model,” Stem Cell Research and Therapy, vol. 6, no. 1, article 101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  135. J. Huelsken and W. Birchmeier, “New aspects of Wnt signaling pathways in higher vertebrates,” Current Opinion in Genetics and Development, vol. 11, no. 5, pp. 547–553, 2001. View at Publisher · View at Google Scholar · View at Scopus
  136. A. B. Coda, V. Qafalijaj Hysa, K. Seiffert-Sinha, and A. A. Sinha, “Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity,” Genes and Immunity, vol. 11, no. 7, pp. 531–541, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Reddy, T. Andl, A. Bagasra et al., “Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis,” Mechanisms of Development, vol. 107, no. 1-2, pp. 69–82, 2001. View at Publisher · View at Google Scholar · View at Scopus
  138. G. S. Eisenbarth, “Type 1 diabetes: molecular, cellular and clinical immunology,” Advances in Experimental Medicine and Biology, vol. 552, pp. 306–310, 2004. View at Google Scholar · View at Scopus
  139. X. He, W. Han, S.-X. Hu, M.-Z. Zhang, J.-L. Hua, and S. Peng, “Canonical Wnt signaling pathway contributes to the proliferation and survival in porcine pancreatic stem cells (PSCs),” Cell and Tissue Research, vol. 362, no. 2, pp. 379–388, 2015. View at Publisher · View at Google Scholar · View at Scopus
  140. G. D. Weinstein, J. L. McCullough, and P. A. Ross, “Cell kinetic basis for pathophysiology of psoriasis,” Journal of Investigative Dermatology, vol. 85, no. 6, pp. 579–583, 1985. View at Publisher · View at Google Scholar · View at Scopus
  141. M. Romanowska, A. Evans, D. Kellock et al., “Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon,” PLoS ONE, vol. 4, no. 4, Article ID e5354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. J. Han, Y. Lee, K.-H. Yeom, Y.-K. Kim, H. Jin, and V. N. Kim, “The Drosha-DGCR8 complex in primary microRNA processing,” Genes and Development, vol. 18, no. 24, pp. 3016–3027, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. S. K. Singh, M. Pal Bhadra, H. J. Girschick, and U. Bhadra, “MicroRNAs—micro in size but macro in function,” FEBS Journal, vol. 275, no. 20, pp. 4929–4944, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. L. T. Jeker and R. Marone, “Targeting microRNAs for immunomodulation,” Current Opinion in Pharmacology, vol. 23, pp. 25–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  145. J. L. Marques-Rocha, M. Samblas, F. I. Milagro, J. Bressan, J. A. Martínez, and A. Marti, “Noncoding RNAs, cytokines, and inflammation-related diseases,” The FASEB Journal, vol. 29, no. 9, pp. 3595–3611, 2015. View at Publisher · View at Google Scholar · View at Scopus
  146. S. Mahmood, A. Bhatti, N. A. Syed, and P. John, “The microRNA regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases,” Journal of Receptors and Signal Transduction, vol. 36, no. 3, pp. 310–318, 2016. View at Publisher · View at Google Scholar
  147. K. M. Pauley and S. Cha, “miRNA-146a in rheumatoid arthritis: a new therapeutic strategy,” Immunotherapy, vol. 3, no. 7, pp. 829–831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  148. D. Liu, H. Zhao, S. Zhao, and X. Wang, “MicroRNA expression profiles of peripheral blood mononuclear cells in patients with systemic lupus erythematosus,” Acta Histochemica, vol. 116, no. 5, pp. 891–897, 2014. View at Publisher · View at Google Scholar · View at Scopus
  149. I. Györy, S. Boller, R. Nechanitzky et al., “Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells,” Genes and Development, vol. 26, no. 7, pp. 668–682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. S. Luo, Y. Liu, G. Liang et al., “The role of microrna-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus,” Clinical Epigenetics, vol. 7, no. 1, article 24, 2015. View at Publisher · View at Google Scholar · View at Scopus
  151. J. Stanczyk, D. M. Leslie Pedrioli, F. Brentano et al., “Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 58, no. 4, pp. 1001–1009, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. B. Qin, F. Huang, Y. Liang, Z. Yang, and R. Zhong, “Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 543–550, 2013. View at Publisher · View at Google Scholar · View at Scopus